Liminatus Pharma, Inc. Class A Common Stock LIMN Q2 2025 earnings
Reported October 3, 2025 · Before market open
Next report
Date not yet announcedVersus estimates
Diluted EPS
Ask the moment Liminatus Pharma, Inc. Class A Common Stock reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Liminatus Pharma, Inc. Class A Common Stock report Q2 2025 earnings?
- Liminatus Pharma, Inc. Class A Common Stock (LIMN) reported Q2 2025 earnings on October 3, 2025 before market open.
- What were Liminatus Pharma, Inc. Class A Common Stock's Q2 2025 revenue and EPS?
- Liminatus Pharma, Inc. Class A Common Stock reported diluted EPS of $-0.05 for Q2 2025.
- Where can I find Liminatus Pharma, Inc. Class A Common Stock's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001104659-25-096872) directly on SEC EDGAR. The filing index links above go to sec.gov.